Current Status of the National Cancer Screening Program in Korea: History, Achievements, and Future Directions
Journal of Preventive Medicine and Public Health · 31.07.2025 · 58 (4) · 337-347
DOI: 10.3961/jpmph.25.268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Preventive Medicine and Public Health, erschienen am 31.07.2025. Verfasst von Kyeongmin Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea. Hauptthemen laut MEDLINE: Early Detection of Cancer, Neoplasms, Mass Screening. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center.
Abstract (Originalsprache)
Cancer is the leading cause of morbidity and mortality worldwide. To reduce this burden, the Korean government established the National Cancer Screening Program (NCSP) in 1999, initially offering stomach, breast, and cervical cancer screening to Medical Aid Program (MAP) beneficiaries. By 2019, the NCSP had broadened both its eligible population and the range of cancers screened—stomach, liver, cervical, breast, colorectal, and lung—for both MAP recipients and health insurance beneficiaries. Since its inception, participation and adherence to recommended screening have risen steadily, driven by nationwide policy initiatives and expanded access. Over the past 2 decades, the NCSP has played a key role in reducing the incidence of stomach, liver, colorectal, and cervical cancers while increasing detection at precancerous stages, especially for cervical and colorectal cancers. Five-year relative survival rates for major cancers—most notably stomach, colorectal, and breast—have also improved substantially. Accumulated evidence, including cancer detection rates, stage distribution at diagnosis, and mortality reduction, underscores the program’s effectiveness in facilitating early detection and reducing cancer-specific deaths. Notably, Korea’s mortality-to-incidence ratio for major cancers remains well below the Organization for Economic Cooperation and Development average, illustrating the impact of the nation’s comprehensive cancer control strategies. Continued research, surveillance, and refinement of evidence-based screening guidelines will be critical to further enhancing the efficiency and effectiveness of the NCSP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
- National Cancer Control Institute, National Cancer Center, Goyang, Korea.
Förderung
- National Cancer Center
Zitieren
APA
Lee, K., Suh, M., & Choi, K. S. (2025). Current Status of the National Cancer Screening Program in Korea: History, Achievements, and Future Directions. Journal of Preventive Medicine and Public Health, 58(4), 337-347. https://doi.org/10.3961/jpmph.25.268
Vancouver
Lee K, Suh M, Choi KS. Current Status of the National Cancer Screening Program in Korea: History, Achievements, and Future Directions. Journal of Preventive Medicine and Public Health. 2025;58(4):337-347. doi:10.3961/jpmph.25.268
BibTeX
@article{Lee2025,
author = {Lee, Kyeongmin and Suh, Mina and Choi, Kui Son},
title = {Current Status of the National Cancer Screening Program in Korea: History, Achievements, and Future Directions},
journal = {Journal of Preventive Medicine and Public Health},
year = {2025},
volume = {58},
number = {4},
pages = {337--347},
doi = {10.3961/jpmph.25.268}
}
EUVIMED